Balyasny Asset Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Buy
2024
Q3
Hold
2024
Q2
Hold
2024
Q1
Sell
2023
Q4
$1.16M Buy
2018
Q3
Sell
2018
Q2
$265K Buy
2018
Q1
$102K Buy